Infecciones de los tejidos blandos (página 2)

11. Bessereau J, Tabah A, Genotelle N, et al. Middle-ear barotrauma after hyperbaric oxygen therapy. Undersea Hyperb Med 2010; 37:203.

12. Bryant AE, Bayer CR, Huntington JD, Stevens DL. Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. J Infect Dis 2006; 193:1685.

13. Bryant AE, Chen RY, Nagata Y, et al. Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis 2000; 182:799.

14. Bryant AE, Chen RY, Nagata Y, et al. Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gp IIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis 2000; 182:808.

15. Butterworth SA, Murphy JJ. Necrotizing soft tissue infections–are they different in healthy vs immunocompromised children? J Pediatr Surg 2006; 41:935.

16. Castleberg E, MD, Jenson n, MD, Am Dinh V, MD. Diagnosis of Necrotizing Faciitis With Bedside Ultrasound: The STAFF Exam. Western J Emerg Med. 2014;15(1):111-113. 

17. Centers for Disease Control and Prevention (CDC). Update: Clostridium novyi and unexplained illness among injecting-drug users–Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000; 49:543.

18. Cole P; Heller L; Bullocks J; Hollier LH; Stal S. Chapter 16. The Skin and Subcutaneous Tissue, in Brunicardi FC, Andersen DK,Billiar TR, Dunn DL, Hunter JG, Matthews JB, Pollock RE. Schwartz's Principles of Surgery, 9e The McGraw-Hill Companies. 2010.

19. Crum NF, Wallace MR: Group B streptococcal necrotizing fasciitis and toxic shock-like syndrome: A case report and review of the literature. Scand J Infect Dis 35:878, 2003.  [PubMed: 14723367].

20. Darenberg J, Ihendyane N, Sjölin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003; 37:333.

21. Darenberg J, Luca-Harari B, Jasir A, et al. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 2007; 45:450.

22. Das DK, Baker MG, Venugopal K. Increasing incidence of necrotizing fasciitis in New Zealand: a nationwide study over the period 1990 to 2006. J Infect 2011; 63:429.

23. Eke N. Fournier's gangrene: a review of 1726 cases. Br J Surg 2000; 87:718.

24. El-Khani U, Nehme J, Darwish A, et al. Multifocal necrotising fasciitis: an overlooked entity? J Plast Reconstr Aesthet Surg 2012; 65:501.

25. Eneli I, Davies HD. Epidemiology and outcome of necrotizing fasciitis in children: an active surveillance study of the Canadian Paediatric Surveillance Program. J Pediatr 2007; 151:79.

26. Fung HB, Chang JY, Kuczynski S: A practical guide to the treatment of complicated skin and soft tissue infections. Drugs 63:1459, 2003.  [PubMed: 12834364].

27. Geraci G , Pisello F, Lupo F, Cajozzo M, Sciumè C , Modica G. Fournier's gangrene: case report and review of recent literature.Ann Ital Chir. 2004 Jan-Feb;75(1):97-106.

28. Hart, GB, Lennon, PA, Strauss, MB. Hyperbaric oxygen in exceptional blood-loss anemia. J Hyperb Med 1987; 2:205.

29. Hasham S, Matteucci P, Stanley PR, Hart NB. Necrotising fasciitis. BMJ 2005; 330:830.

30. Hau V, Ho CO. Necrotising fasciitis caused by Vibrio vulnificus in the lower limb following exposure to seafood on the hand. Hong Kong Med J 2011; 17:335.

31. Holland MJ. Application of the Laboratory Risk Indicator in Necrotising Fasciitis (LRINEC) score to patients in a tropical tertiary referral centre. Anaesth Intensive Care 2009; 37:588.

32. Howard RJ: Necrotizing fasciitis. Surg Gynecol Obstet 161:357, 1985.

33. Howell GM, Rosengart MR. Necrotizing soft tissue infections. Surg Infect (Larchmt). 2011; 12:185–190.

34. Huang KF, Hung MH, Lin YS, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma 2011; 71:467.

35. Jallali N: Necrotizing fasciitis: Its aetiology, diagnosis and management. J Wound Care 12:297, 2003.  [PubMed: 14533236].

36. Jamal N, Teach SJ. Necrotizing fasciitis. Pediatr Emerg Care 2011; 27:1195.

37. Kaide CG, Khandelwal S. Hyperbaric oxygen: applications in infectious disease. Emerg Med Clin North Am 2008; 26:571.

38. Kainer MA, Linden JV, Whaley DN, et al. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 2004; 350:2564.

39. Kimura AC, Higa JI, Levin RM, et al. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis 2004; 38:e87.

40. Kuncir EJ, Tillou A, St. Hill CR, et al: Necrotizing soft-tissue infections. Emerg Med Clin North Am 21:1075, 2003.  [PubMed: 14708819]

41. Lasocki S , Geffroy A , Montravers P . Necrotizing cutaneous infections and Fournier's gangrene. Ann Fr Anesth Reanim. 2006 Sep; 25(9):971-4.

42. Lorber B. Gas gangrene and other Clostridium-associated diseases. In: Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.2828.

43. Majeski JA, John JF Jr: Necrotizing soft tissue infections: A guide to early diagnosis and initial therapy. South Med J 96:900, 2003.  [PubMed: 14513988].

44. Marín Pérez AL, Toledo Santana N, Marín Hernández A. VIH y Gangrena de Fournier. Presentación y análisis de casos. Revista Médica Electrónica 2008;30(2).

45. Massey PR, Sakran JV, Mills AM, et al. Hyperbaric oxygen therapy in necrotizing soft tissue infections. J Surg Res. 2012;177:146–151.

46. McGuigan CC, Penrice GM, Gruer L, et al. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol 2002; 51:971.

47. McLellan E, Suvarna K, Townsend R. Fatal necrotizing fasciitis caused by Haemophilus influenzae serotype f. J Med Microbiol 2008; 57:249.

48. Meleney FL: Bacterial synergism in disease processes with confirmation of synergistic bacterial etiology of certain types of progressive gangrene of the abdominal wall. Ann Surg 94:961, 1931.

49. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445.

50. MINSAP.Diccionario Terminológico de Ciencias Médicas.XI ed. La Habana:Cientifico Técnica; 1978.p .327 .

51. Mullangi PK, Khardori NM. Necrotizing soft-tissue infections. Med Clin N Am. 2012;96:1193–1202.

52. Nordkild P, Crone P. Spontaneous clostridial myonecrosis. A collective review and report of a case. Ann Chir Gynaecol 1986; 75:274.

53. Norrby-Teglund A, Muller MP, Mcgeer A, et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis 2005; 37:166.

54. O'Loughlin RE, Roberson A, Cieslak PR, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007; 45:853.

55. Panesar K RPh, CPh. Necrotizing Soft-Tissue Infections 'Flesh-Eating Bacteria'. US Pharmacist. 2013;38(4):HS-8-HS-12. 

56. Petitpas F, Blancal JP, Mateo J, et al. Factors associated with the mediastinal spread of cervical necrotizing fasciitis. Ann Thorac Surg 2012; 93:234.

57. Planelles Gómez J , Vergés Prósper A , Rubio Tortosa I , Beltrán Armada JR , Carrascosa Lloret V , San Juan de Laorden C . Fournier's gangrene. Arch Esp Urol. 2006 Oct;59(8):767-71

58. Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002; 35:950.

59. Resman F, Svensjö T, Ünal C, et al. Necrotizing myositis and septic shock caused by Haemophilus influenzae type f in a previously healthy man diagnosed with an IgG3 and a mannose-binding lectin deficiency. Scand J Infect Dis 2011; 43:972.

60. Sablier F, Slaouti T, Drèze PA, et al. Nosocomial transmission of necrotising fasciitis. Lancet 2010; 375:1052.

61. Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concepts and review of the literature. J Am Coll Surg. 2009;208:279–288.

62. Schwartz MN, Pasternack MS. Cellulitis and subcutaneous tissue infections. In: Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia 2005. p.1172.

63. Simonart T, Simonart JM, Derdelinckx I, et al. Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis. Clin Infect Dis 2001; 32:E9.

64. Soh CR, Pietrobon R, Freiberger JJ, et al. Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. Intensive Care Med 2012; 38:1143.

65. Stevens DL, Titball RW, Jepson M, et al. Immunization with the C-Domain of alpha -Toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens. J Infect Dis 2004; 190:767.

66. Stevens DL, Tweten RK, Awad MM, et al. Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J Infect Dis 1997; 176:189.

67. Stevens DL, MD, PhD, Bryant A, PhD, Bartlett JG, Section Editor, Baron EL, MD, DTMH. Clostrideal Myonecrosis. Updated January 2014 UpToDate, Inc. http://www.uptodate.com/contents/clostridial-myonecrosis.

68. Stumvoll M, Fritsche A. Necrotizing fasciitis caused by unencapsulated Haemophilus influenzae. Clin Infect Dis 1997; 25:327.

69. Sullivan C, PhD, MBBCh, Sullivan P, MD, MBBCh, Eadie P, MD, MBBCh, Veale D, MD, MBBCh. Necrotizing Fasciitis in Patients on Methotrexate. Therapy.J Clin Rheumatol. 2013;19(5):289-291. 

70. Thekkemuriyi DV, John SG, Pillai U. 'Krokodil'–a designer drug from across the Atlantic, with serious consequences. Am J Med 2014; 127:e1.

71. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996; 334:1642.

72. Torp KD, Carraway MS, Ott MC, et al. Safe administration of hyperbaric oxygen after bleomycin: a case series of 15 patients. Undersea Hyperb Med 2012; 39:873.

73. Ustin JS, Malangoni MA. Necrotizing soft-tissue infections. Crit Care Med. 2011;39:2156–2162.

74. Walls T, Williams G, Adams S, et al. Neonatal necrotising fasciitis following superficial skin infection with community-associated methicillin-resistant Staphylococcus aureus. J Paediatr Child Health 2011; 47:918.

75. Wilkinson D, Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg 2004; 139:1339.

76. Wilson MP, Schneir AB. A case of necrotizing fasciitis with a LRINEC score of zero: clinical suspicion should trump scoring systems. J Emerg Med 2013; 44:928.

77. Wong CH, Chang HC, Pasupathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am 2003; 85-A:1454.

78. Yaghoubian A, de Virgilio C, Dauphine C, et al. Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft-tissue infections. Arch Surg 2007; 142:840.

79. Yeniyol CO, Suelozgen T, Arslan M, Ayder AR. Fournier's gangrene: experience with 25 patients and use of Fournier's gangrene severity index score. Urology 2004; 64:218.

80. Zacharias N, Velmahos GC, Salama A, et al. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg 2010; 145:452.